6949
沛爾生醫*-創
-5.80 (-9.86%)53.0013,467成交張數–本益比27.04股價淨值比0.00%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | -0.07 | – | -0.36 | -0.89 | -993.3% | -3.40% | -24.11% |
| 2026Q1 | -0.06 | – | -0.36 | -0.77 | -1202.6% | -3.75% | -22.49% |
| 2025Q4 | -0.13 | – | -0.36 | -1.52 | -2503.8% | -12.77% | -32.59% |
| 2025Q3 | -0.10 | – | -0.32 | -1.18 | -1570.2% | -11.83% | -33.56% |
| 2025Q2 | -0.07 | – | -0.30 | -0.78 | -1325.4% | -7.20% | -29.67% |
| 2025Q1 | -0.06 | – | – | -0.76 | -634.4% | -6.60% | – |
| 2024Q4 | -0.09 | – | – | -1.02 | -2193.5% | -8.31% | – |
| 2024Q3 | -0.09 | – | – | -1.01 | -2024.9% | -7.68% | – |
| 2024Q2 | -0.09 | – | – | -1.02 | -2025.3% | – | – |